Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$27.82
+2.02%
Mkt Cap $949.99M
Analyst Ratings
Buy
11
Hold
3
Sell
0
Price Target (8 analysts)
$34.60
Range $24.00 – $50.00
Implied Upside
+24.4%
Consensus $34.60 vs current $27.82
NYSE·Healthcare·Biotechnology
$27.82
+2.02%
Mkt Cap $949.99M
Buy
11
Hold
3
Sell
0
Price Target (8 analysts)
$34.60
Range $24.00 – $50.00
+24.4%
Consensus $34.60 vs current $27.82